Relmada appoints Johns Hopkins professor to clinical advisory board
PositiveFinancial Markets

Relmada Therapeutics has made a significant move by appointing a renowned professor from Johns Hopkins University to its clinical advisory board. This appointment is expected to enhance the company's research capabilities and strengthen its position in the healthcare sector. The expertise brought by this professor could lead to innovative approaches in developing treatments, which is crucial for patients and the industry alike.
— Curated by the World Pulse Now AI Editorial System